LONA - Athira Pharma, Inc.
5.3
-0.070 -1.321%
Share volume: 12,517
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$5.37
-0.07
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-01-2024 | 11-07-2024 | 02-27-2025 | 05-09-2025 | 11-06-2025 | |
| Assets | |||||||
| Total Assets | 133.458 M | 111.253 M | 86.246 M | 58.779 M | 43.513 M | 30.033 M | |
| Current Assets | 128.636 M | 106.704 M | 82.002 M | 54.841 M | 39.853 M | 27.025 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.628 M | 1.628 M | 1.628 M | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 44.267 M | 17.941 M | 0.000 | 2.837 M | 10.248 M | 4.352 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 77.821 M | 73.828 M | 68.856 M | 48.438 M | 26.422 M | 20.874 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.144 M | 2.930 M | 2.687 M | 2.444 M | 2.201 M | 1.715 M | |
| Other Assets | 1.678 M | 1.619 M | 1.557 M | 1.494 M | 1.459 M | 1.293 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 133.458 M | 111.253 M | 86.246 M | 58.779 M | 43.513 M | 30.033 M | |
| Total liabilities | 26.716 M | 27.918 M | 28.663 M | 13.938 M | 6.183 M | 3.247 M | |
| Total current liabilities | 25.598 M | 26.902 M | 27.751 M | 13.135 M | 5.492 M | 2.787 M | |
| Accounts Payable | 681.000 K | 475.000 K | 388.000 K | 319.000 K | 867.000 K | 266.000 K | |
| Other liabilities | 1.118 M | 1.016 M | 912.000 K | 803.000 K | 691.000 K | 460.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.118 M | 1.016 M | 912.000 K | 803.000 K | 691.000 K | 460.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 106.742 M | 83.335 M | 57.583 M | 44.841 M | 37.330 M | 26.786 M | |
| Common stock | 442.422 M | 445.775 M | 448.723 M | 450.986 M | 452.623 M | 455.654 M | |
| Retained earnings | -335.543 M | -362.402 M | -391.143 M | -406.146 M | -415.289 M | -428.866 M |